CloudSeq is a Singapore based company providing complete solution for NGS (Next Generation Sequencing) based Clinical Genomics diagnostics. Built on the established domain expertise and track records of its founders, CloudSeq secured funding from Singapore National Research Foundation (NRF) and Expara to develop a Cloud based interactive digital platform that can cater to the burgeoning demand for NGS services across all Life Sciences sectors.

CloudSeq successfully partnered with NSCC (National Super Computing Centre, Singapore) and also with A*CRC to host the CloudSeq platform on their High Performance Computing (HPC) Clusters, which is one of the most powerful globally. We have developed, tested and patented (pending) automated Clinical Genomics workflows on these clusters and aim to serve the rapidly emerging sector of Precision Medicine through our myClinGen platform. CloudSeq is a revenue generating company with diverse case studies from SEA and India. CloudSeq aims to be among the first in this region to lead genomics based diagnostics market for clinics, hospitals, corporates and individuals.

The CloudSeq (myClinGen) services commence with delivery of test kits to clinics and hospital users which are qualified to collect tissue (e.g. blood and/or saliva) samples from consenting patients. The samples are collected with anonymised data at the source location. The samples are then sent to a partnering CLIA/ CAP accredited DNA Sequencing laboratory that provides commercial whole genome/exome sequencing services and Targeted NGS Sequencing services. This lab is equipped with latest Illumina and PacBio sequencers. NGS data generated in this lab gets automatically and securely uploaded to CloudSeq platform hosted on NSCC/A*CRC HPC clusters using the state-of-the-art Infiniband technology . CloudSeq NGS workflows are then executed to analyse the data against custom curated NCBI databases, which is hosted in US and globally shared and updated daily.